A core domain set for pyoderma gangrenosum trial outcomes: an international eDelphi and consensus study from the UPGRADE initiative

M. E. Jacobson(Oregon Health & Science University), Ben Kaffenberger, Wenelia Baghoomian(Oregon Health & Science University), Jonathan W. Rick(University of Arkansas for Medical Sciences), Philip Hampton(National Health Service), M. Imre, Michael J. Jacobson(Oregon Health & Science University), Joachim Dissemond(Essen University Hospital), Kim S Thomas(University of Nottingham), Barbara Nolan, Marcia Friedman(Oregon Health & Science University), Alex G. Ortega‐Loayza(Oregon Health & Science University), Antonios G.A. Kolios(University Hospital of Bern), Amit Garg(Northwell Health), Louise A. A. Gerbens(Amsterdam UMC Location University of Amsterdam), Jean L. Bolognia(Yale University), Diana M. Chen, Daniel Wallach(AGroécologie, Innovations, teRritoires), Debbie L Oakes(South Shore Hospital), David Croitoru(University of Toronto), Maurice Moelleken(Essen University Hospital), Toshiyuki Yamamoto(Fukushima Medical University), Ashley Gray, Luca Borradori(University Dermatology), Afsáneh Alavi(Mayo Clinic in Arizona), Hans Herfarth(University of North Carolina at Chapel Hill), Kanade Shinkai(University of California, San Francisco), Lisa J. Gould(Kent Hospital), Carlo Alberto Maronese(University of Milan), Dan Lobato, Angelo Valerio Marzano(University of Milan)
British Journal of Dermatology
November 11, 2023
Cited by 6


Related Papers